BUSINESSCBC NEWS
Loblaw boosts profit on generic GLP-1 drug sales, bargain hunting shoppers
Loblaw, Canada's largest grocer, is boosting profits by focusing on generic GLP-1 drug sales, which have seen a 40 per cent year-to-date sales increase. The company attributes this growth to bargain-hunting shoppers and a new business strategy.
Related Signal
Adjacent reporting
- Dollar Tree’s sales top forecasts as fewer people are shopping — but they’re spending more
- GLP-1 Craze Fuels Protein-Powder Maker Glanbia’s Share Rally
- FedEx is chasing the GLP-1 boom. Why healthcare logistics means big business
- Can GLP-1 drugs save the mall?
- Bristol Myers Squibb is raising its full-year outlook after blood thinner sales surged past expectations